<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03484078</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00004873</org_study_id>
    <nct_id>NCT03484078</nct_id>
  </id_info>
  <brief_title>Effect of Vibration on Muscle Properties, Physical Activity and Balance in Children With Cerebral Palsy</brief_title>
  <official_title>Effect of Vibration on Muscle Properties, Physical Activity and Balance in Children With Cerebral Palsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Georgia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Georgia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the 6-month randomized controlled trial, with 6-month no treatment follow-up, is&#xD;
      to examine the effects of low-magnitude vibration on muscle, physical activity, and balance&#xD;
      in children with spastic cerebral palsy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cerebral palsy (CP) is a movement disorder that affects over 800,000 people in the U.S. Due&#xD;
      to the limited mobility associated with the disorder, individuals with CP have an increased&#xD;
      risk of chronic diseases, such as cardiovascular disease, diabetes mellitus and osteoporosis,&#xD;
      compared to the general population. Therefore, identifying treatment strategies is of utmost&#xD;
      importance. The aim of this study is to examine the acute and chronic effects of&#xD;
      low-magnitude vibration on muscle, physical activity, and balance in children with CP. Fat&#xD;
      concentration and muscle will be assessed using imaging techniques. Physical activity will be&#xD;
      assessed using activity monitors. Balance will be assessed using clinical and biomechanical&#xD;
      tests. Children with CP will be tested at five time points: baseline, 1 and 6 months after&#xD;
      standing on a vibration platform daily 10 minutes per day, 1 and 6 months post treatment (7&#xD;
      months and 12 months from baseline, respectively). The findings from the proposed study will&#xD;
      help us determine if vibration shows promise as a treatment for the impaired mobility, lower&#xD;
      physical activity and higher risk of chronic disease in individuals with CP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 23, 2019</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Children with CP will be randomly assigned to a vibration or a placebo group.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in fat concentration</measure>
    <time_frame>Baseline, 6 months and 12 months</time_frame>
    <description>Change in fat concentration assessed using imaging techniques</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in muscle size</measure>
    <time_frame>Baseline, 6 months and 12 months</time_frame>
    <description>Change in muscle size assessed using imaging techniques</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in physical activity</measure>
    <time_frame>Baseline, 1 month, 6 months, 7 months, and 12 months</time_frame>
    <description>Change in physical activity assessed using activity monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dynamic balance</measure>
    <time_frame>Baseline, 1 month, 6 months, 7 months, and 12 months</time_frame>
    <description>Change in dynamic balance assessed using step recovery method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in static balance</measure>
    <time_frame>Baseline, 1 month, 6 months, 7 months, and 12 months</time_frame>
    <description>Change in static balance assessed using force plates</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Cerebral Palsy, Spastic</condition>
  <arm_group>
    <arm_group_label>Vibration Platform</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The vibration group will stand on a platform that emits a mild vibration 10 minutes per day for 6 months. There will also be a 6 month no-treatment period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Platform</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo group will stand on a placebo platform 10 minutes per day for 6 months. There will also be a 6 month no-treatment period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vibration Platform</intervention_name>
    <description>The vibration platform will emit a mild vibration when the participant stands on it 10 minutes per day for 6 months.</description>
    <arm_group_label>Vibration Platform</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo Platform</intervention_name>
    <description>The placebo platform will not vibrate when the participant stands on it 10 minutes per day for 6 months.</description>
    <arm_group_label>Placebo Platform</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Spastic cerebral palsy&#xD;
&#xD;
          -  Independent ambulator without an assistive device (Gross Motor Function Classification&#xD;
             System level I or II)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior fractures in both femurs or tibias&#xD;
&#xD;
          -  Currently taking bisphosphonates&#xD;
&#xD;
          -  Unable to stand independently&#xD;
&#xD;
          -  Orthopedic surgery on a lower extremity within the last 6 months&#xD;
&#xD;
          -  Children with pure athetoid CP&#xD;
&#xD;
          -  Baclofen pump in the abdomen&#xD;
&#xD;
          -  Botox treatment within the last year&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher M Modlesky, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Georgia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sydni V Wilhoite, MS</last_name>
    <phone>706-395-5085</phone>
    <email>uga.cp.research@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Georgia</name>
      <address>
        <city>Athens</city>
        <state>Georgia</state>
        <zip>30602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sydni V Wilhoite, MS</last_name>
      <phone>706-395-5085</phone>
      <email>uga.cp.research@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>March 13, 2018</study_first_submitted>
  <study_first_submitted_qc>March 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2018</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Georgia</investigator_affiliation>
    <investigator_full_name>Christopher Modlesky</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

